EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort

Nikita Ermolaev iD, Wolfgang N Löscher, Nicolas Verheyen, Gerhard Pölzl, Klemens Ablasser, Hermine Agis, Christina Binder iD, Diana Bonderman, Hakan Cetin, Franz Duca iD, Theresa Antonia Griedl, Sandra Hacker und 18 weitere

Journal of Clinical Medicine · 04.03.2026 · 15 (5) · 1958

DOI: 10.3390/jcm15051958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.03.2026. Verfasst von Nikita Ermolaev und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Hereditary transthyretin amyloidosis (ATTRv) is a heterogeneous multisystem disease caused by pathogenic transthyretin gene (TTR) variants. Increased awareness and availability of disease-modifying therapies have resulted in increased diagnoses, even in previously nonendemic regions. The aim of this study was to update the nationwide Austrian ATTRv registry by characterizing the clinical, genetic, and regional distribution of TTR variants.

Methods

This multicenter, observational analysis examined ATTRv cases diagnosed in Austria between 2014 and 2025. Individuals were included according to the presence of pathogenic or likely pathogenic variants or variants of uncertain significance (VUSs) in TTR.

Results

In total, 100 individuals were identified, including symptomatic and asymptomatic carriers. Compared with our previously presented data, the number of genetically confirmed ATTRv cases has more than doubled. Twenty-three TTR variants were identified. The most frequent pathologic variants were p.His108Arg (26%), p.Ile127Phe (11%), and p.Thr69Ile (9%), while p.Val113Leu (9%) represented the most frequent VUS. Significant regional clustering of p.His108Arg was documented in Vienna and Lower Austria. Other findings included a rising number of p.Val142Ile carriers and phenotypically relevant VUSs in 20 patients.

Conclusions

Our findings revealed an increasing detection rate of ATTRv in a nonendemic European region. These data underscore the importance of multidisciplinary evaluation, cascade testing, and long-term monitoring to improve early diagnosis and timely management in hereditary amyloidosis.

Schlagwörter

Stichwörter der Autor:innen

ATTR amyloidosisAustriaTTR variantsgenetic screeningregional distribution

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Cardiology, University Heart Center Graz, 8036 Graz, Austria.
  • Department of Cardiology, Medial University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Nikita Ermolaev, Christina Binder, Franz Duca, Viktoria Höller, Andreas Kammerlander, Lukas Kellermair, Christina Kronberger, Michael Poledniczek, Rene Rettl, Lena Marie Schmid, Nora Schwegel, Raute Sunder-Plassmann, Maria Ungericht, Reinhard Windhager, Roza Badr Eslam

Förderung

  • Pfizer
  • Austrian Science Fund

Zitieren

APA

Ermolaev, N., Löscher, W. N., Verheyen, N., Pölzl, G., Ablasser, K., Agis, H., Binder, C., Bonderman, D., Cetin, H., Duca, F., Griedl, T. A., Hacker, S., Höller, V., Kammerlander, A., Kellermair, L., Kleinveld, V. E. A., Kronberger, C., Mörtl, D., Poledniczek, M., …, & Auer-Grumbach, M. (2026). Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort. Journal of Clinical Medicine, 15(5), 1958. https://doi.org/10.3390/jcm15051958

Vancouver

Ermolaev N, Löscher WN, Verheyen N, Pölzl G, Ablasser K, Agis H, et al. Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort. Journal of Clinical Medicine. 2026;15(5):1958. doi:10.3390/jcm15051958

BibTeX
@article{Ermolaev2026,
  author = {Ermolaev, Nikita and Löscher, Wolfgang N and Verheyen, Nicolas and Pölzl, Gerhard and Ablasser, Klemens and Agis, Hermine and Binder, Christina and Bonderman, Diana and Cetin, Hakan and Duca, Franz and Griedl, Theresa Antonia and Hacker, Sandra and Höller, Viktoria and Kammerlander, Andreas and Kellermair, Lukas and Kleinveld, Vera E A and Kronberger, Christina and Mörtl, Deddo and Poledniczek, Michael and Reiter, Christian and Rettl, Rene and Schmid, Lena Marie and Schwegel, Nora and Schaumberger, Elisabeth and Sunder-Plassmann, Raute and Ungericht, Maria and Windhager, Reinhard and Zimprich, Fritz and Badr Eslam, Roza and Auer-Grumbach, Michaela},
  title = {Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {1958},
  doi = {10.3390/jcm15051958}
}
Kostenlos starten →